TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

BACKGROUND: Tumour surveillance via induction of TRAIL-mediated apoptosis is a key mechanism, how the immune system prevents malignancy. To determine if gene variants in the TRAIL receptor I (DR4) gene affect the risk of hepatitis C virus (HCV)-induced liver cancer (HCC), we analysed DR4 mutations C...

Descripción completa

Detalles Bibliográficos
Autores principales: Körner, Christian, Riesner, Katarina, Krämer, Benjamin, Eisenhardt, Marianne, Glässner, Andreas, Wolter, Franziska, Berg, Thomas, Müller, Tobias, Sauerbruch, Tilman, Nattermann, Jacob, Spengler, Ulrich, Nischalke, Hans Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372437/
https://www.ncbi.nlm.nih.gov/pubmed/22401174
http://dx.doi.org/10.1186/1471-2407-12-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372437/
https://www.ncbi.nlm.nih.gov/pubmed/22401174
http://dx.doi.org/10.1186/1471-2407-12-85

Ejemplares similares